Class 4 Medicines Defect Information: Esomeprazole 40mg Powder for Solution for Injection/Infusion
DEMO SA PHARMACEUTICAL INDUSTRY has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that the Product Code/GTIN (PC) number found on a specific batch of Esomeprazole 40mg Powder (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 31, 2022 Category: Drugs & Pharmacology Source Type: news

Vimovo (naproxen and esomeprazole magnesium)
Title: Vimovo (naproxen and esomeprazole magnesium)Category: MedicationsCreated: 5/12/2021 12:00:00 AMLast Editorial Review: 5/12/2021 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - May 12, 2021 Category: Rheumatology Source Type: news

Janssen Announces U.S. FDA Approval of CABENUVA (rilpivirine and cabotegravir), the First Long-Acting Regimen for the Treatment of HIV
TITUSVILLE, N.J., January 21, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved CABENUVA (consisting of Janssen’s rilpivirine and ViiV Healthcare’s cabotegravir), the first and only once-monthly, long-acting regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults. The novel regimen was co-developed as part of a collaboration with ViiV Healthcare and builds on Janssen’s 25-year commitment to make HIV history. In the U.S., ViiV Healthcare is the marketing authorization holder for CABENUVA.C...
Source: Johnson and Johnson - January 22, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in US
The drug major is recalling esomeprazole magnesium for delayed-release oral suspension in unit dose packets in strengths 10 mg, 20 mg and 40 mg in the US market, the latest Enforcement Report by the USFDA said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 10, 2021 Category: Pharmaceuticals Source Type: news

Common Heartburn Drugs May Be Tied to Higher COVID Risk
TUESDAY, July 14, 2020 -- Popular heartburn medications such as Prilosec (omeprazole) and Nexium (esomeprazole) may inadvertently up your chances of catching COVID-19, new research suggests. An online survey of more than 53,000 Americans, all with a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 14, 2020 Category: General Medicine Source Type: news

Taste disorder ’s management: a systematic review
ConclusionImproving oral hygiene may promote taste ability. Zinc may prevent and alleviate taste disorder in patients undergoing head and neck radiotherapy.Clinical relevanceThe systematic review provided evidence about the clinical efficacy of oral procedures, zinc supplementation, and palliative cares in dysgeusic patients. Further research is needed to find effective treatments with low adverse effects. (Source: Dental Technology Blog)
Source: Dental Technology Blog - May 14, 2020 Category: Dentistry Source Type: news

FDA Calls For Heartburn Drug Zantac To Be Pulled From Market Immediately
(CNN) — The US Food and Drug Administration is requesting that manufacturers pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately, the agency announced on Wednesday. The FDA noted that an ongoing investigation has determined that levels of a contaminant in the heartburn medications increase over time and when stored at higher-than-normal temperatures, poses a risk to public health. The contaminant, N-nitrosodimethylamine or NDMA, is a probable human carcinogen and the FDA has been investigating levels of it in ranitidine since the summer of 2019. ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 1, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Zantac Source Type: news

Cipla Receives Final Approval for Generic Version of AstraZeneca Pharmaceutical's Nexium(R) (Esomeprazole for Oral Suspension 10mg, 20mg and 40mg)
Cipla is the first company to file for the 10mg strength MUMBAI, India, March 27, 2020 -- (Healthcare Sales & Marketing Network) -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and hereafter referred to as "Cipla") today announced that it has ... Biopharmaceuticals, Generics, FDA Cipla, Esomeprazole, Nexium, AstraZeneca (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 27, 2020 Category: Pharmaceuticals Source Type: news

Cipla gets USFDA nod for generic acid reflux drug
The company has received final approval for its abbreviated new drug application (ANDA) for Esomeprazole for oral suspension in the strengths of 10mg, 20mg and 40mg from the United States Food and Drug Administration (USFDA), Cipla said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 25, 2020 Category: Pharmaceuticals Source Type: news

Could Heartburn Meds Lead to Drug-Resistant Germs?
The findings do not prove that PPIs -- which include popular brands such as Prilosec (omeprazole), Prevacid (lansoprazole) and Nexium (esomeprazole) -- are the cause, experts said.         But they are the latest to raise safety questions about the top-selling prescription and over-the-counter medicines. (Source: WebMD Health)
Source: WebMD Health - February 25, 2020 Category: Consumer Health News Source Type: news

Sun Pharma gets partial relief from US court in litigation involving three generic drugs
Drug major Sun Pharma is a defendant in a multi-district litigation brought by various classes of plaintiffs in the US District Court (District of Massachusetts), alleging a delay in the market entry for three generic drugs -- Valganciclovir, Valsartan and Esomeprazole. The company said it would continue to vigorously defend against all claims. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 1, 2019 Category: Pharmaceuticals Source Type: news

CVS Halts Sale of Heartburn Treatment Zantac as FDA Warns of Contaminants
CVS has halted sales of popular heartburn treatment Zantac and its generic store brand after warnings by U.S. health regulators. It’s the latest precautionary move by retailers and manufacturers after the U.S. Food and Drug Administration recently warned consumers about a potentially dangerous contaminant in prescription and over-the-counter versions of Zantac. In its announcement this weekend, CVS said customers who bought Zantac products can return them for a refund. The retailer will continue to sell other heartburn medications. What’s the issue? In September, the FDA said it detected low levels of a probabl...
Source: TIME: Health - September 30, 2019 Category: Consumer Health News Authors: LINDA A. JOHNSON / AP Tags: Uncategorized medicine onetime Source Type: news

Overuse of heartburn drugs linked to heart, kidney disease, cancer
Researchers have linked popular drugs like Prevacid, Prilosec, Nexium and other proton pump inhibitors to a higher risk of death by cardiovascular and chronic kidney disease, as well as upper gastrointestinal cancer. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 30, 2019 Category: Consumer Health News Source Type: news

Esomeprazole Magnesium Capsules (esomeprazole magnesium) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 21, 2019 Category: Drugs & Pharmacology Source Type: news

esomeprazole (Nexium)
Title: esomeprazole (Nexium)Category: MedicationsCreated: 5/8/2001 12:00:00 AMLast Editorial Review: 3/1/2019 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - March 1, 2019 Category: Nutrition Source Type: news